數位糖尿病管理市場：按類型、產品類型和地區分類

Digital Diabetes Management Market, By Type , By Product, By Geography

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年數位糖尿病管理市場規模為171.4億美元，預計2033年將達到717.7億美元。預計2026年至2033年，該市場將以22.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	171.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	22.70%	2033年市場規模預測：	717.7億美元

智慧胰島素筆、智慧胰島素幫浦、智慧血糖儀和持續血糖監測儀等數位化糖尿病管理設備可以幫助糖尿病患者（第一型和第2型糖尿病）監測和管理血糖值。因此，隨著全球糖尿病盛行率的上升，對技術先進的糖尿病管理設備（數位化糖尿病管理設備）的需求也迅速成長。

市場動態

人工智慧 (AI) 應用於糖尿病管理設備、對數位糖尿病管理設備的需求不斷成長，以及公眾對糖尿病護理和技術先進的糖尿病管理設備的好處的認知不斷提高，預計這些因素將推動全球數位糖尿病管理市場在預測期內成長。

例如，2022年11月，禮來公司（LLY）宣布計畫在美國推出首個互聯平台－Tempo個人化糖尿病管理平台。該平台旨在幫助1型或2型糖尿病患者和臨床醫生做出基於數據的明智決策，以更好地管理禮來公司的胰島素治療方案。

此外，2022年3月，Medtronic力印度有限公司宣佈在印度推出「MiniMed 780G」系統。「MiniMed 780G」系統是一款新一代閉合迴路胰島素幫浦系統，設計用於治療7至80歲的第一型糖尿病患者。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據公司亮點、產品系列、主要功能、財務表現和策略等參數，創建了全球數位糖尿病管理市場主要公司的概況。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球數位糖尿病管理市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球數位糖尿病管理市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 17.14 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	22.70%	2033 Value Projection:	USD 71.77 Bn

Digital diabetes management devices, like smart insulin pens, smart insulin pumps, smart glucose meter, and continuous blood glucose monitoring devices, help people with diabetes (type I and II) to monitor and manage their glucose levels. Thus, with the increasing prevalence of diabetes across the globe, the demand for technologically advanced diabetes management devices (digital diabetes management devices) is also increasing with a rapid pace.

Market Dynamics

Rise in burden of diabetes, growing geriatric population, introduction of artificial intelligence (AI) in diabetes management devices, increasing demand for digital diabetes management devices, and increasing awareness among people about diabetes care and benefits of technologically advanced diabetes management devices are major factors expected to propel the growth of the global digital diabetes management market over the forecast period.

For instance, in November 2022, Eli Lilly and Company (LLY) planned to rollout first connected platform, the Tempo Personalized Diabetes Management Platform, in the U.S. The platform aims to help individuals living with type 1 or type 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins.

Moreover, in March 2022, India Medtronic Private Limited announced the launch of the MiniMed 780G system in India. The MiniMed 780G system is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global digital diabetes management market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, F. Hoffmann-la Roche Ltd., Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, Terumo Corporation, Dexcom, Inc., and Becton, Dickinson and Company, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global digital diabetes management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital diabetes management market.

Market Segmentation

Global Digital Diabetes Management Market, By Type (Revenue, USD Bn, 2021 - 2033)
Handheld Devices
Wearable Devices
Global Digital Diabetes Management Market, By Product (Revenue, USD Bn, 2021 - 2033)
Continuous Blood Glucose Monitoring Systems
Smart Glucose Meter
Smart Insulin Pumps
Smart Insulin Pens
Apps
Global Digital Diabetes Management Market, By Geography (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Global Digital Diabetes Management Market: Key Companies Insights
Abbott Laboratories
Acon Laboratories, Inc.
Bayer AG
Hoffmann-la Roche Ltd.
Johnson and Johnson
Medtronic Plc
Novo Nordisk A/S
Terumo Corporation
Dexcom, Inc.
Becton, Dickinson and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of diabetes around the world
- High cost of digital diabetes management devices
- Increasing demand for digital management devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Digital Diabetes Management Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Handheld Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Wearable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Digital Diabetes Management Market, By Product, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Continuous Blood Glucose Monitoring Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Smart Glucose Meter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Smart Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Smart Insulin Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Digital Diabetes Management Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)

7. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Acon Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-la Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dexcom, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views